CRL options flow: unusual options activity in Charles River Laboratories International, Inc.

Updated 19 November 2026, 22:00 ET

Over the last week the tape recorded 8 unusual options prints in Charles River Laboratories International, Inc. (CRL), $698K of tracked premium, leaning bearish. Bullish premium was $287K against $411K bearish; $252K went into calls and $446K into puts, a put call ratio of 1.77. The largest print was $145K of CRL 20 Nov 2026 $330 puts on 18 November 2026, swept at bid. The last session with prints, 18 November 2026, added 4 prints and $296K of premium. CRL closed at $327.93 on 19 November 2026, down 1.6%.

This week's unusual flow

Unusual prints8
Tracked premium$698K
Net premium-$124K
Bullish premium$287K
Bearish premium$411K
Call premium$252K
Put premium$446K
P/C ratio1.77
Sweeps75%
Size over OI1
Whale prints0
High conviction1

Prints from 13 November 2026 to 18 November 2026, 3 sessions. Delayed tier: every print is shown twenty minutes after it executed, and the page is rebuilt after each session.

Net premium is bullish minus bearish premium. The put call ratio is put premium divided by call premium, weighted by money rather than by contract count. Sweeps is the share of prints executed across several exchanges at once. Read the guide: Reading the Pulse.

Largest prints of the week

DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
18 Nov 2026CRL 20 Nov 2026 $330 putsSweep350815$145KAt bidBullishNotable
13 Nov 2026CRL 18 Dec 2026 $330 callsSweep5361$139KAt bidBearishNotable
13 Nov 2026CRL 20 Nov 2026 $340 putsTrade100153$132KAt askBearish
13 Nov 2026CRL 18 Dec 2026 $330 putsSweep6015$95KAt bidBullishHigh conviction
18 Nov 2026CRL 21 May 2027 $480 callsSweep56159$77KAt bidBearishNotable
18 Nov 2026CRL 20 Nov 2026 $340 putsSweep61349$47KAt bidBullish
17 Nov 2026CRL 19 Feb 2027 $300 callsTrade6125$37KAt bidBearish
18 Nov 2026CRL 20 Nov 2026 $340 putsSweep40349$28KAt askBearishNotable

Size above open interest means the trade opened a position larger than everything that existed in the contract the night before. Above ask and below bid are the most aggressive executions. Read the guide: Size versus open interest.

Where the money is aimed

ExpiryPrintsPremiumCalls shareNet premium
20 Nov 20264$351K0%+$32K
18 Dec 20262$234K59%-$43K
21 May 20271$77K100%-$77K
19 Feb 20271$37K100%-$37K

The most premium, $351K, is aimed at the 20 Nov 2026 expiry.

A print in a contract expiring this week is a view about the next few days, often about a known event; a print months out is a different kind of statement. Read the guide: 0DTE options flow.

The last session, 18 November 2026

Prints4
Premium$296K
Net premium+$87K
P/C ratio2.86
Sweeps100%
DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
18 Nov 2026CRL 20 Nov 2026 $330 putsSweep350815$145KAt bidBullishNotable
18 Nov 2026CRL 21 May 2027 $480 callsSweep56159$77KAt bidBearishNotable
18 Nov 2026CRL 20 Nov 2026 $340 putsSweep61349$47KAt bidBullish
18 Nov 2026CRL 20 Nov 2026 $340 putsSweep40349$28KAt askBearishNotable

Every print in CRL with its full detail, the live tape, one tap filters and saved screeners: open CRL in Options Sentiment Screener.

Price

Last close$327.93
Day-1.60%
1 week-3.78%
1 month-4.91%
3 months+11.09%
1 year+101.77%
52 week high$379.63
52 week low$146.19
Volume495,099
Market cap$15.9B

The live quote and the price chart sit beside the ticker's flow in the app: open CRL in Options Sentiment Screener.

Analysts

The most recent analyst targets on file, from 12 firms, have a median of $337, 2.8% above the last close.

Calls bought at a strike above the average target are a bet that the analysts are too cautious; puts far below the price in a name they like are protection or a strong disagreement. Read the guide: Reading one ticker's flow.

About Charles River Laboratories International, Inc.

Exchange
NYSE
Sector
Health Care
Industry
Business Services
Headquarters
Wilmington, Massachusetts
Website
criver.com

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services. The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies. The Manufacturing segment provides in vitro testing of sterile and non-sterile pharmaceuticals and consumer products.

In the same sector

Flow pages for other Health Care names in the S&P 500:

LLY Eli Lilly & Co.JNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group Inc.MRK Merck & Co. Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.

Learn

The live tape for CRL with every print's execution detail, one tap filters for calls, puts, sweeps and 0DTE, saved screeners and, for Realtime subscribers, push alerts and no delay. The same screen is in the iOS and Android apps.

Open CRL in Options Sentiment Screener